Patents by Inventor Maxime LAUGEOIS

Maxime LAUGEOIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MACROCYCLIC LRRK2 KINASE INHIBITORS
    Publication number: 20240246992
    Abstract: Compounds of formula (I) are useful as LRRK2 kinase inhibitors.
    Type: Application
    Filed: March 17, 2022
    Publication date: July 25, 2024
    Inventors: Audrey DUMOULIN, Petra Marcella BLOM, Alain DAUGAN, Maxime LAUGEOIS, Christopher Gaétan HOUSSEMAN, Alexis DENIS, Yann LAMOTTE, Arnaud LE TIRAN, Kenneth CHRISTENSEN
  • NEW MACROCYCLIC LRRK2 KINASE INHIBITORS
    Publication number: 20230357269
    Abstract: Compounds of Formula (I): wherein R, X1, X2, X3, Z1, Z2, Z3, A and Ra are as defined in the description.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 9, 2023
    Inventors: Petra Marcella BLOM, Christopher Gaètan HOUSSEMAN, Alain DAUGAN, Audrey DUMOULIN, Maxime LAUGEOIS, Alexis DENIS, Nicolas FAUCHER, Iuliana BOTEZ, Arnaud LE TIRAN, Kenneth CHRISTENSEN, Yann LAMOTTE